Clinical Guidelines > Current Guidelines >

BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022 - consultation open

Introduction

The overall purpose of these guidelines is to provide guidance on best clinical practice for antiretroviral therapy (ART) and management of adults living with HIV. The scope includes: (i) guidance on the initiation of ART in those previously naïve to therapy; (ii) support of people living with HIV on treatment; (iii) management of individuals experiencing virological failure; and (iv) recommendations for specific populations where other factors need to be taken into consideration. The guidelines are for clinical professionals directly involved with and responsible for the care of adults living with HIV, and community advocates responsible for promoting the best interests and care of adults living with HIV. They should be read in conjunction with other published BHIVA guidelines.

The consultation will be open for 1 month until 5.00pm on Thursday 9 June 2022.


Downloads

Consultation version of the BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022 - fully referenced

Consultation version of the BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022 - without updated references

Appendices
Appendix 1 Summary of the modified GRADE system
Appendix 2 PICO questions and literature search strategies
Appendix 3 New studies/comparisons (11 November 2021)

Declaration of interest
Declaration of conflict of interest for the writing group


Please leave feedback via the form below.